The gene expression of both α-SMA and MMP-13 showed an apparent up-regulation in NASH rats compared with control rats from the 30th day; contrasting results were observed for TGF-β from the 20th day. The gene discussed is MMP13; the disease is metabolic dysfunction-associated steatohepatitis.